Literature DB >> 18155171

Different roles of SHIP1 according to the cell context: the example of blood platelets.

Marie-Pierre Gratacap1, Sonia Séverin, Gaëtan Chicanne, Monique Plantavid, Bernard Payrastre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18155171     DOI： 10.1016/j.advenzreg.2007.11.004

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN： 0065-2571


× No keyword cloud information.
  3 in total

1.  LNK/SH2B3 Loss of Function Promotes Atherosclerosis and Thrombosis.

Authors:  Wei Wang; Yang Tang; Ying Wang; Liana Tascau; Joanna Balcerek; Wei Tong; Ross L Levine; Carrie Welch; Alan R Tall; Nan Wang
Journal:  Circ Res       Date:  2016-07-18       Impact factor: 17.367

2.  Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer.

Authors:  Gwenny M Fuhler; Robert Brooks; Bonnie Toms; Sonia Iyer; Elizabeth A Gengo; Mi-Young Park; Matthew Gumbleton; Dennis R Viernes; John D Chisholm; William G Kerr
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

3.  In-depth PtdIns(3,4,5)P3 signalosome analysis identifies DAPP1 as a negative regulator of GPVI-driven platelet function.

Authors:  Tom N Durrant; James L Hutchinson; Kate J Heesom; Karen E Anderson; Len R Stephens; Phillip T Hawkins; Aaron J Marshall; Samantha F Moore; Ingeborg Hers
Journal:  Blood Adv       Date:  2017-06-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.